Differential Expression of MicroRNAs in Chronic Obstructive Pulmonary Disease

dc.contributor.authorKara, Murat
dc.contributor.authorKirkil, Gamze
dc.contributor.authorKalemci, Serdar
dc.date.accessioned2026-08-12T17:16:53Z
dc.date.issued2016
dc.departmentFırat Üniversitesi
dc.description.abstractBackground. This study aimed to investigate the associations of miRNA with COPD patients. Objectives. Chronic obstructive pulmonary disease (COPD) is characterized by progressive and largely irreversible airflow limitation. COPD is one of the most common causes of death globally and it is still a serious public health problem worldwide. Pathogenesis of COPD is multifactorial including genetics and environmental factors. Material and Methods. Sixty patients who were diagnosed with COPD according to GOLD guidance and 40 controls were involved in the study. This study was separated into four groups according to GOLD guidance. miR_16, miR_17, miR_29c, miR_92, miR_125, miR_126, miR_146, miR_155, miR_181, mir_122 expressions from the total miRNAs obtained were worked on by using real time-PCR method. The p-values are calculated based on a Student's t-test of the replicate 2(boolean AND) (-Delta Ct) values for each gene in the control group. Results. The miRNAs expressions in normal and COPD patients were found differentially. The miR-29c (p = 0.043) and -126 (p = 0.012) were found significantly different compared to control group. When their expressions are evaluated according to stage, miR-92 expression showed down regulation stage II and no change was observed in other miRNAs. miR-29c and miR-126 expressions showed significant differences in stage III and only miR-126 expression showed significant difference in stage IV. Conclusions. These results show that miRNA evaluations may give information about the diagnosis, staging and prognosis of the disease. In this study, we demonstrated that miR-29c and -126 are essential for the development of COPD
dc.description.sponsorshipFIRAT University Scientific Research Projects [TF.12.73]
dc.description.sponsorshipThis study was supported by grants from the FIRAT University Scientific Research Projects Unit (No. TF.12.73).
dc.identifier.doi10.17219/acem/28343
dc.identifier.endpage26
dc.identifier.issn1899-5276
dc.identifier.issn2451-2680
dc.identifier.issue1
dc.identifier.pmid26935494
dc.identifier.scopus2-s2.0-84963777937
dc.identifier.scopusqualityQ1
dc.identifier.startpage21
dc.identifier.urihttps://doi.org/10.17219/acem/28343
dc.identifier.urihttps://hdl.handle.net/11508/52452
dc.identifier.volume25
dc.identifier.wosWOS:000372182800003
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWroclaw Medical Univ
dc.relation.ispartofAdvances in Clinical and Experimental Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectCOPD
dc.subjectMicroRNAs
dc.subjectsmoking cigarettes
dc.titleDifferential Expression of MicroRNAs in Chronic Obstructive Pulmonary Disease
dc.typeArticle

Dosyalar